Current evidence suggests that PKR accumulates in the brain and cerebrospinal fluid in patients with AD and mild cognitive impairment, leading to TNFα and IL1-β production (Hugon et al., 2017). This evidence concerns the gene EIF2AK2 and Cognitive impairment.